Expert Analysis

Highlight on Special Hepatic Issues and Populations

Source: CCO Independent Conference Coverage of the 2008 Annual Meeting of the European Association for the Study of the Liver*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Highlight on Special Hepatic Issues and Populations

Faculty:

Robert G. Gish, MD
Josep M. Llovet, MD
Paul Martin, MD

CREDIT INFORMATION

Release Date: June 23, 2008

Expiration Date: June 22, 2009

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.3 Nursing contact hours

Pharmacists: 1.3 contact hours (0.13 CEUs)

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss recent data concerning insulin resistance and viral hepatitis
Describe new insights into management strategies for patients with hepatocellular carcinoma and those undergoing liver transplantation
Recount developing strategies for the management of autoimmune hepatitis
Recount recent data concerning noninvasive approaches to the assessment of nonalcoholic fatty liver disease

Topics covered include:

HBV Infection and Insulin Resistance
Use of Metformin Plus Peginterferon alfa-2a/Ribavirin Among Treatment-Naive Genotype 1 HCV-Infected Patients With Insulin Resistance
Insulin Resistance and Fibrosis Progression in Posttransplantation Hepatitis C Patients
Biomarkers Panel to Identify Patients With Nonalcoholic Steatohepatitis
Simvastatin and Portal Hypertension in Cirrhotic Patients
Risk Score for Predicting Long-term Probability of HCC Development in Chronic Hepatitis B Patients
Identification of 5 Chronic Hepatitis C–Related HCC Subclasses via Integrative Genomic Analysis
Use of Sorafenib Following Previous Therapies in Advanced HCC
Use of Sorafenib in Unresectable HCC and Advanced Liver Cirrhosis
Use of Sirolimus in Cirrhotic Patients With Advanced HCC
Y90 Glass Microsphere Radioembolization for Inoperable HCC Patients
Impact of Race on Survival After Orthotopic Liver Transplantation
Posttransplantation Survival in Patients With Autoimmune Hepatitis
Combination Therapy With Budesonide and Azathioprine for the Treatment of AIH

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.